Skip to main content
. 2014 Oct 21;2014:627673. doi: 10.1155/2014/627673

Table 3.

Influence of sodium bicarbonate therapy on chronic kidney disease progression.

Type of study Patients number Main finding Limitations Reference
Randomized, single center 134 Patients supplemented with oral sodium bicarbonate are less likely to experience rapid progression of kidney disease. Serum bicarbonate level in participants was 16 to 20 mM, limiting external validity. de Brito-Ashurst et al., 2009 [73]
Prospective 59 The rate of estimated glomerular filtration rate (eGFR) decline was slower in patients who received sodium citrate. The control group was composed of patients that were unable to take the medication. Phisitkul et al., 2010 [75]
Prospective, randomized, controlled 120 The rate of cystatin C-eGFR decline is slower in patients given sodium bicarbonate. The reduction in the rate of progression is not observed using other estimates of kidney function. Mahajan et al., 2010 [76]